Northland Capital Markets Initiates Coverage On Cardio Diagnostics Hldgs With Outperform Rating, Announces Price Target of $8
Northland Capital Markets Initiates Coverage On Cardio Diagnostics Hldgs With Outperform Rating, Announces Price Target of $8
Northland Capital Markets启动了对评级跑赢大盘的Cardio Diagnostics控股的报道,宣布目标股价为8美元
Northland Capital Markets analyst Carl Byrnes initiates coverage on Cardio Diagnostics Hldgs (NASDAQ:CDIO) with a Outperform rating and announces Price Target of $8.
Northland Capital Markets分析师卡尔·伯恩斯以跑赢大盘的评级开始对Cardio Diagnostics Hldgs(纳斯达克股票代码:CDIO)进行报道,并宣布目标股价为8美元。